Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK

被引：0
|
作者：
Johnston, K. [1 ]
Powell, L. [1 ]
Popoff, E. [1 ]
L'Italien, G. [2 ]
Pawinski, R. [3 ]
Ahern, A. [3 ]
Large, S. [3 ]
Tran, T. [4 ]
Jenkins, A. [3 ]
机构：
[1] Broadst Hlth Econ & Outcomes Res, Vancouver, BC, Canada
[2] Biohaven Pharmaceut Inc, New Haven, CT USA
[3] Pfizer Ltd, Tadworth, England
[4] Pfizer Canada, Kirkland, PQ, Canada
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P038
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
    Hardik Goswami
    Adnan Alsumali
    Yiling Jiang
    Matthias Schindler
    Elizabeth R. Duke
    Joshua Cohen
    Andrew Briggs
    Amy Puenpatom
    PharmacoEconomics, 2023, 41 : 605 - 605
  • [42] COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH ORAL BISPHOSPHONATES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Hiligsmann, M.
    Reginster, J. Y.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 30 - 31
  • [43] COST-EFFECTIVENESS OF IMATINIB AS ADJUVANT TREATMENT FOR RESECTED GASTROINTESTINAL STROMAL TUMORS (GIST) VERSUS BEST SUPPORTIVE CARE: CANADIAN PERSPECTIVE
    El Ouagari, K.
    Pawar, V
    Coombs, J.
    Rubin, J.
    VALUE IN HEALTH, 2010, 13 (07) : A270 - A270
  • [44] A pharmacoeconomic model of the cost-effectiveness of gefitinib ("Iressa") compared with best supportive care (BSC) in third-line treatment of patients with refractory advanced non-small-cell lung cancer (NSCLC) in the UK
    Ratcliffe, AE
    Beard, SM
    Wolowacz, S
    VALUE IN HEALTH, 2004, 7 (06) : 675 - 676
  • [45] COST-EFFECTIVENESS OF HOME HOSPICE PALLIATIVE AND SUPPORTIVE CARE - RESPONSE
    SMITH, TJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (01) : 64 - 64
  • [46] Cost-Effectiveness of Initial Prophylactic Treatment of Chronic Migraine: Oral Medications versus OnabotulinumtoxinA
    Kelley, Kristin
    Schoenbrunner, Anna
    Murphy, James
    NEUROLOGY, 2016, 86
  • [47] The cost-effectiveness of supportive periodontal care for patients with chronic periodontitis
    Gaunt, Francesca
    Devine, Maria
    Pennington, Mark
    Vernazza, Chris
    Gwynnett, Erika
    Steen, Nick
    Heasman, Peter
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2008, 35 : 67 - 82
  • [48] Cost-effectiveness of a digital supportive healthcare pathway for type 2 diabetes compared to usual care in Belgium
    Van Wilder, Lisa
    De Smedt, Delphine
    Sandra, Lieselotte
    Vandormael, Dorien
    Kaes, Joyce
    Willems, Ruben
    Trybou, Jeroen
    DIGITAL HEALTH, 2025, 11
  • [49] Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK
    Guest, Julian F.
    Clegg, John P.
    Helter, Marianne T.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (07) : 1841 - 1852
  • [50] COST-EFFECTIVENESS OF EDOXABAN COMPARED TO WARFARIN FOR THE TREATMENT AND SECONDARY PREVENTION OF VENOUS THROMBOEMBOLISM IN THE UK
    Clay, E.
    Jamotte, A.
    Cohen, A. T.
    van Hout, B.
    Gumbs, P. D.
    Verhamme, P.
    VALUE IN HEALTH, 2016, 19 (07) : A653 - A654
12345